Vadakekolathu, J., Skuli, S., Boocock, D. J., Coveney, C., Ikpo, E. G., Wang, B., … Rutella, S. (2024). Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures. In Blood (Vol. 144, pp. 2911–2911). American Society of Hematology. https://doi.org/10.1182/blood-2024-201311

Vadakekolathu, Jayakumar, Sarah Skuli, David J. Boocock, Clare Coveney, Eruchi G. Ikpo, Bofei Wang, Elena M. Fenu, et al. “Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures.” In Blood, 144:2911–2911. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-201311.

Vadakekolathu J, Skuli S, Boocock DJ, Coveney C, Ikpo EG, Wang B, et al. Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures. In: Blood. American Society of Hematology; 2024. p. 2911–2911.

Vadakekolathu, Jayakumar, et al. “Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 2911–2911. Crossref, doi:10.1182/blood-2024-201311.

Vadakekolathu J, Skuli S, Boocock DJ, Coveney C, Ikpo EG, Wang B, Fenu EM, Abbas HA, Lai CE, Carroll MP, Rutella S. Multi-Omic Analyses of TP53-Mutated Acute Myeloid Leukemia Identify Prognostic Metabolic Signatures. Blood. American Society of Hematology; 2024. p. 2911–2911.